Danaher Co. (NYSE:DHR) Shares Sold by Roanoke Asset Management Corp NY

Roanoke Asset Management Corp NY trimmed its position in shares of Danaher Co. (NYSE:DHR) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,979 shares of the conglomerate’s stock after selling 589 shares during the period. Roanoke Asset Management Corp NY’s holdings in Danaher were worth $3,897,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of DHR. Heck Capital Advisors LLC purchased a new position in Danaher during the 4th quarter valued at about $27,000. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher during the fourth quarter worth about $31,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher during the fourth quarter worth about $31,000. Teachers Insurance & Annuity Association of America purchased a new position in shares of Danaher in the third quarter valued at approximately $39,000. Finally, MidAtlantic Capital Management Inc. acquired a new position in shares of Danaher in the third quarter valued at approximately $40,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 11.10% of the stock is currently owned by insiders.

Danaher Stock Performance

Shares of DHR stock opened at $207.73 on Friday. The stock’s 50-day moving average is $224.58 and its two-hundred day moving average is $245.09. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The firm has a market cap of $148.47 billion, a price-to-earnings ratio of 39.34, a PEG ratio of 2.66 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the firm posted $2.09 EPS. Analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.32 per share. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.62%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is currently 24.24%.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent research reports. Raymond James reissued a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. Robert W. Baird cut their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Wells Fargo & Company decreased their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Finally, Guggenheim started coverage on shares of Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.